Prelude Therapeutics Inc (PRLD) valuation · rev $12.1M
Prelude Therapeutics Inc (PRLD) rev $12.1M.
| Metric | Value |
|---|---|
| Market cap | $346.5M |
| Revenue | $12.1M |
| P/S | 28.5 |
| P/B | 5.7 |
PRLD valuation FAQ
What is PRLD's market cap?
Prelude Therapeutics Inc (PRLD) market cap is $346.5M on the latest cached fundamentals snapshot.
What is PRLD's latest revenue?
Latest cached Prelude Therapeutics Inc (PRLD) revenue was $12.1M. Statements: https://lician.com/financials/prld
What is PRLD's price-to-sales ratio?
Prelude Therapeutics Inc (PRLD) price-to-sales (P/S) is 28.5, cached market cap $346.5M divided by revenue $12.1M.
What is PRLD's price-to-book ratio?
Prelude Therapeutics Inc (PRLD) price-to-book (P/B) is 5.7 on the latest cached fundamentals snapshot.
How many PRLD valuation scalars are listed on this page?
This page lists 4 cached valuation scalars for Prelude Therapeutics Inc (PRLD): Market cap, Revenue, P/S, and P/B.
Where is PRLD valuation listed?
Cached valuation multiples for Prelude Therapeutics Inc (PRLD) are listed at https://lician.com/valuation/prld.
Not investment advice. Cached rows, not a live tape.